Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: SOLTYS, KATHY
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (2)
Results: 1-2 | Export
  1. Psychedelics Canada—The Canada Psychedelic Businesses Association
    Type: In-house Organization
    Occurred: 2023-06-13
    Posted: 2023-07-27
    Designated public office holders:
    • Daniel Keene, Associate Director, Office of Clinical Trials | Health Canada (HC)
    • Jennifer Pelley, Director, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Kathy Soltys, Director, Office of Clinical Trials | Health Canada (HC)
    • Carol Anne Chénard, Director, Office of Controlled Substances | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Justice and Law Enforcement
      •
  2. Psychedelics Canada—The Canada Psychedelic Businesses Association
    Type: In-house Organization
    Occurred: 2022-10-04
    Posted: 2022-11-15
    Designated public office holders:
    • Cesare Spadaccini, Manager, Office of Controlled Substances | Health Canada (HC)
    • Marc-André Roy, Associate Director, Office of Controlled Substances | Health Canada (HC)
    • Jenny-Lee Choon, Acting Manager, Office of Controlled Substances | Health Canada (HC)
    • Daniel Keene, Associate Director, Office of Clinical Trials | Health Canada (HC)
    • Jennifer Pelley, Director, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Kristen Beausoleil, Manager, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Jennifer Saxe, Director General, Controlled Substances Directorate, Controlled Substances and Cannabis Branch | Health Canada (HC)
    • Kathy Soltys, Director, Office of Clinical Trials | Health Canada (HC)
    • Sarah Schlegelmilch, Senior Policy Analyst, Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Graeme Simpson, Senior Policy Analyst, Office of Controlled Substances | Health Canada (HC)
    • Jaigi Mathai, Senior Evaluator, Office of Clinical Trials | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Justice and Law Enforcement
      •
Date Modified: